wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34627112-499D3A5F-3C39-4944-9EC8-4BDAA5D0C222
Q34627112-499D3A5F-3C39-4944-9EC8-4BDAA5D0C222
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34627112-499D3A5F-3C39-4944-9EC8-4BDAA5D0C222
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
P2860
Q34627112-499D3A5F-3C39-4944-9EC8-4BDAA5D0C222
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34627112-499D3A5F-3C39-4944-9EC8-4BDAA5D0C222
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
44ef5d808ba2da576615238ae6777d23945cb802
P2860
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.